Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit September 26, 2017 <b>Hip Innovation Technology</b> Initiates Clinical Trial Of Its Novel Hip Replacement System For The Treatment Of Total Hip Arthroplasty August 8, 2017 <b>Numares AG</b> Achieves Key Milestone: Identifies Candidate Metabolomic Network For Bladder Cancer Diagnostics July 12, 2017
<b>Hip Innovation Technology</b> Initiates Clinical Trial Of Its Novel Hip Replacement System For The Treatment Of Total Hip Arthroplasty August 8, 2017
<b>Numares AG</b> Achieves Key Milestone: Identifies Candidate Metabolomic Network For Bladder Cancer Diagnostics July 12, 2017
